Medial Frontal GABA is Lower in Older Schizophrenia: A MEGA-PRESS with Macromolecule Suppression Study
暂无分享,去创建一个
Peter Kochunov | L. Elliot Hong | S. A. Wijtenburg | Laura M Rowland | Ben Krause | P. Kochunov | L. Rowland | L. Hong | J. Chiappelli | S. Andrea Wijtenburg | Benjamin W. Krause | Robert P. McMahon | Joshua Chiappelli | Katie L. Nugent | Sarah J. Nisonger | Stephanie A. Korenic | R. Mcmahon | S. Korenic | Katie L Nugent
[1] A. Stan,et al. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. , 2012, Current pharmaceutical biotechnology.
[2] A M McIntosh,et al. Working memory in schizophrenia: a meta-analysis , 2008, Psychological Medicine.
[3] R. Fisher. 014: On the "Probable Error" of a Coefficient of Correlation Deduced from a Small Sample. , 1921 .
[4] Arvind Caprihan,et al. Use of tissue water as a concentration reference for proton spectroscopic imaging , 2006, Magnetic resonance in medicine.
[5] J. Mugler,et al. Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE) , 1990, Magnetic resonance in medicine.
[6] Peter R Luijten,et al. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. , 2013, Schizophrenia bulletin.
[7] Deanna M. Barch,et al. Cognition in schizophrenia: core psychological and neural mechanisms , 2012, Trends in Cognitive Sciences.
[8] S. Woods,et al. Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.
[9] R. Edden,et al. Gannet: A batch‐processing tool for the quantitative analysis of gamma‐aminobutyric acid–edited MR spectroscopy spectra , 2014, Journal of magnetic resonance imaging : JMRI.
[10] Dost Öngür,et al. Elevated Gamma-Aminobutyric Acid Levels in Chronic Schizophrenia , 2010, Biological Psychiatry.
[11] S. Kéri,et al. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: The potential impact of GABA concentration in the visual cortex , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[12] D. Glahn,et al. Dedifferentiation and substitute strategy: Deconstructing the processing-speed impairment in schizophrenia , 2012, Schizophrenia Research.
[13] A. Sampson,et al. Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.
[14] Mark Slifstein,et al. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. , 2012, Archives of general psychiatry.
[15] Junghee Lee,et al. Working memory impairments in schizophrenia: a meta-analysis. , 2005, Journal of abnormal psychology.
[16] A. Meyer-Lindenberg,et al. Absence of changes in GABA concentrations with age and gender in the human anterior cingulate cortex: A MEGA‐PRESS study with symmetric editing pulse frequencies for macromolecule suppression , 2013, Magnetic resonance in medicine.
[17] Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. , 2010, The American journal of psychiatry.
[18] J. Gold,et al. Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale , 2012, Schizophrenia Research.
[19] J. Krystal,et al. Sex, GABA, and nicotine: The impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy , 2005, Biological Psychiatry.
[20] E. G. Jones,et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.
[21] D. Hines,et al. Disrupting the clustering of GABAA receptor α2 subunits in the frontal cortex leads to reduced γ-power and cognitive deficits , 2013, Proceedings of the National Academy of Sciences.
[22] Yogesh K. Dwivedi,et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.
[23] Lars-Göran Nilsson,et al. Age-related white matter microstructural differences partly mediate age-related decline in processing speed but not cognition. , 2012, Biochimica et biophysica acta.
[24] Jong H. Yoon,et al. GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression , 2010, The Journal of Neuroscience.
[25] A. Graff-Guerrero,et al. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study. , 2013, JAMA psychiatry.
[26] Society of magnetic resonance in medicine , 1990 .
[27] Wenyaw Chan,et al. Statistical Methods in Medical Research , 2013, Model. Assist. Stat. Appl..
[28] F. Benes,et al. GABAergic Interneurons: Implications for Understanding Schizophrenia and Bipolar Disorder , 2001, Neuropsychopharmacology.
[29] J. J. Ryan,et al. Wechsler Adult Intelligence Scale-III , 2001 .
[30] Huiquan Wang,et al. Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels , 2013, NeuroImage.
[31] R. Yoshimura,et al. No alterations of brain GABA after 6months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[32] D. Barch,et al. The Cognitive Neuroscience of Working Memory: Relevance to CNTRICS and Schizophrenia , 2008, Biological Psychiatry.
[33] M. Garwood,et al. Simultaneous in vivo spectral editing and water suppression , 1998, NMR in biomedicine.
[34] D. Lewis,et al. Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.
[35] H. M. Morris,et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.
[36] S. A. Wijtenburg,et al. In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. , 2013, Schizophrenia bulletin.
[37] D. Dickinson. Digit symbol coding and general cognitive ability in schizophrenia: worth another look? , 2008, British Journal of Psychiatry.
[38] Philip D. Harvey,et al. Is schizophrenia a syndrome of accelerated aging? , 2008, Schizophrenia bulletin.
[39] W. Cleveland,et al. Locally Weighted Regression: An Approach to Regression Analysis by Local Fitting , 1988 .
[40] David A Lewis,et al. GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. , 2005, Current neuropharmacology.
[41] Sarah H. Lisanby,et al. Neuroimage: Clinical Gaba Level, Gamma Oscillation, and Working Memory Performance in Schizophrenia , 2022 .
[42] D. R. Curtis,et al. GABA, Bicuculline and Central Inhibition , 1970, Nature.
[43] A. Guidotti,et al. Should allosteric positive modulators of GABAA receptors be tested in the treatment of schizophrenia? , 2005, Schizophrenia Research.
[44] Randolph C. Arnau,et al. Second Order Confirmatory Factor Analysis of the WAIS-III , 2000, Assessment.
[45] Philip D. Harvey,et al. Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. , 2008, Journal of psychiatric research.
[46] D. Lewis,et al. Alterations of Cortical GABA Neurons and Network Oscillations in Schizophrenia , 2010, Current psychiatry reports.
[47] Peter Kochunov,et al. Multimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophrenia , 2014, Psychiatry Research: Neuroimaging.
[48] Elisa Conti,et al. Progress in Neuro-Psychopharmacology & Biological Psychiatry , 2012 .
[49] E. Bora. Neurodevelopmental origin of cognitive impairment in schizophrenia , 2014, Psychological Medicine.
[50] Susan N. Wright,et al. Accelerated white matter aging in schizophrenia: role of white matter blood perfusion , 2014, Neurobiology of Aging.
[51] J. Gold,et al. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. , 2007, Archives of general psychiatry.
[52] A. Graff-Guerrero,et al. Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study. , 2013, The international journal of neuropsychopharmacology.
[53] Philip D. Harvey,et al. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) , 2008, Schizophrenia Research.
[54] A. Graff-Guerrero,et al. Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis , 2011, Neuropsychopharmacology.
[55] N. Woodward,et al. Processing speed impairment in schizophrenia is mediated by white matter integrity , 2014, Psychological Medicine.
[56] D. Jeste,et al. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. , 2011, Schizophrenia bulletin.
[57] G. Bloch,et al. Brain GABA editing without macromolecule contamination , 2001, Magnetic resonance in medicine.